Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics

Cyclophosphamide mechanism of action on DNA showing the inter- and intrastrand crosslinks that cause DNA damage and trigger apoptosis in cancer cells (a) and its metabolic pathway showing its bioactivation from a prodrug to an active agent and its terminal cytotoxic metabolites (b)
Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics

Publication

Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics (2024) Ibrahim El-Serafi, et al. Adv Pharmacol Pharm Sci. 2024;2024(NA). Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID